CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 637	$ 2,164
Other current assets	360	555
Total current assets	997	2,719
Patent license rights, net	549	666
Furniture and equipment, net	0	0
Total assets	1,546	3,385
Current liabilities
Accounts payable	132	124
Other accrued liabilities	56	158
Total current liabilities	188	282
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 150,000,000 shares authorized; 40,885,411 shares in 2015 and 2014 issued and outstanding	20	20
Additional paid-in capital	189,426	189,268
Accumulated deficit	(188,088)	(186,185)
Total Capstone Therapeutics Corp. stockholders' equity	1,358	3,103
Noncontrolling interest	0	0
Total equity	1,358	3,103
Total liabilities and equity	$ 1,546	$ 3,385

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).